Figure 2From: Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trials Power using traditional study design by magnitude of the interaction effect, planned prevalence of the prognostic factor, and misspecification of the prevalence of the prognostic factor. Back to article page